Have your own idea? Try our Stock Screener
Over the last 7 days, the Clinical Research and Equipment industry has dropped 2.4%, driven by AddLife declining 2.2%. Meanwhile, Magle Chemoswed Holding actually outperformed within the industry, gaining 6.7% in the last week. Over the past 12 months, the industry was up 81%. Looking forward, earnings are forecast to grow by 49% annually.
Has the Swedish Clinical Research and Equipment Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Mon, 07 Oct 2024 | SEK 47.2b | SEK 16.7b | -SEK 988,175,491.00 | 58.9x | -47.7x | 2.8x |
Wed, 04 Sep 2024 | SEK 48.6b | SEK 16.7b | -SEK 987,374,492.00 | 61.8x | -49.2x | 2.9x |
Fri, 02 Aug 2024 | SEK 49.2b | SEK 16.7b | -SEK 1,128,120,510.00 | 61.9x | -43.6x | 2.9x |
Sun, 30 Jun 2024 | SEK 42.0b | SEK 16.3b | -SEK 1,188,686,510.00 | 55.3x | -35.3x | 2.6x |
Tue, 28 May 2024 | SEK 43.1b | SEK 16.3b | -SEK 1,188,686,510.00 | 61.1x | -36.2x | 2.6x |
Thu, 25 Apr 2024 | SEK 37.9b | SEK 16.1b | -SEK 1,234,732,213.00 | 36.3x | -30.7x | 2.4x |
Sat, 23 Mar 2024 | SEK 38.9b | SEK 16.0b | -SEK 1,122,792,210.00 | 36x | -34.6x | 2.4x |
Mon, 19 Feb 2024 | SEK 41.0b | SEK 16.0b | -SEK 1,409,735,350.00 | 50.7x | -29.1x | 2.6x |
Wed, 17 Jan 2024 | SEK 36.9b | SEK 15.5b | -SEK 1,393,723,683.00 | 45.2x | -26.5x | 2.4x |
Fri, 15 Dec 2023 | SEK 37.4b | SEK 15.5b | -SEK 1,393,723,683.00 | 46.1x | -26.8x | 2.4x |
Sun, 12 Nov 2023 | SEK 31.2b | SEK 15.4b | -SEK 1,256,647,710.00 | 34x | -24.8x | 2x |
Tue, 10 Oct 2023 | SEK 25.6b | SEK 15.1b | -SEK 1,134,516,711.00 | 36.6x | -22.6x | 1.7x |
Thu, 07 Sep 2023 | SEK 29.6b | SEK 15.1b | -SEK 1,133,372,831.00 | 36.6x | -26.1x | 2x |
Sat, 05 Aug 2023 | SEK 32.1b | SEK 15.1b | -SEK 213,871,038.00 | 46.7x | -150.2x | 2.1x |
Mon, 03 Jul 2023 | SEK 36.5b | SEK 14.6b | -SEK 172,476,038.00 | 36.1x | -211.7x | 2.5x |
Wed, 31 May 2023 | SEK 39.0b | SEK 14.6b | -SEK 173,602,038.00 | 39.4x | -224.6x | 2.7x |
Fri, 28 Apr 2023 | SEK 35.0b | SEK 14.5b | -SEK 110,425,459.00 | 34x | -316.9x | 2.4x |
Sun, 26 Mar 2023 | SEK 31.9b | SEK 14.6b | -SEK 57,185,459.00 | 31x | -557.6x | 2.2x |
Tue, 21 Feb 2023 | SEK 41.8b | SEK 14.4b | SEK 826.4m | 36.4x | 50.6x | 2.9x |
Thu, 19 Jan 2023 | SEK 40.3b | SEK 14.2b | SEK 943.9m | 38.7x | 42.7x | 2.8x |
Sat, 17 Dec 2022 | SEK 39.4b | SEK 14.1b | SEK 944.3m | 41.5x | 41.7x | 2.8x |
Mon, 14 Nov 2022 | SEK 40.0b | SEK 14.1b | SEK 936.8m | 42.1x | 42.7x | 2.8x |
Wed, 12 Oct 2022 | SEK 32.4b | SEK 13.5b | SEK 750.9m | 47.2x | 43.1x | 2.4x |
Fri, 09 Sep 2022 | SEK 37.5b | SEK 13.5b | SEK 751.3m | 54.5x | 49.9x | 2.8x |
Sun, 07 Aug 2022 | SEK 43.7b | SEK 13.2b | SEK 667.8m | 44.6x | 65.4x | 3.3x |
Tue, 05 Jul 2022 | SEK 43.4b | SEK 13.2b | SEK 753.4m | 39x | 57.6x | 3.3x |
Thu, 02 Jun 2022 | SEK 54.8b | SEK 13.2b | SEK 753.4m | 48.2x | 72.8x | 4.1x |
Sat, 30 Apr 2022 | SEK 53.3b | SEK 12.7b | SEK 742.5m | 51.9x | 71.8x | 4.2x |
Mon, 28 Mar 2022 | SEK 60.7b | SEK 11.8b | SEK 746.3m | 53.5x | 81.3x | 5.1x |
Wed, 23 Feb 2022 | SEK 50.6b | SEK 11.4b | SEK 784.8m | 43x | 64.5x | 4.4x |
Fri, 21 Jan 2022 | SEK 69.2b | SEK 10.8b | SEK 786.3m | 46.9x | 88x | 6.4x |
Sun, 19 Dec 2021 | SEK 79.5b | SEK 10.8b | SEK 786.3m | 51.5x | 101.1x | 7.4x |
Tue, 16 Nov 2021 | SEK 88.7b | SEK 10.8b | SEK 788.5m | 54.4x | 112.4x | 8.2x |
Thu, 14 Oct 2021 | SEK 91.2b | SEK 9.9b | SEK 853.6m | 54x | 106.9x | 9.2x |
106.9x
How does Swedish Clinical Research and Equipment compare with similar industries?
SE Market | -1.29% | |
Healthcare | -2.45% | |
Life Sciences | -2.48% | |
Clinical Research and Equipment | -2.48% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
MAGLE Magle Chemoswed Holding | SEK 41.20 | 6.7% +SEK 28.1m | 39.2% | PE57.8x | |
AROC AroCell | SEK 0.52 | 3.0% +SEK 3.5m | 4.0% | PS2.5x | |
PEXA B PExA | SEK 0.47 | 8.1% +SEK 2.0m | 16.7% | PS20.6x |